These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8630721)

  • 1. Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
    Skoner DP; Boltansky H; Kobayashi RH; Pearlman DS; Shapiro G; Harrison JE; Trochelmann LM; Lorber RR
    Ann Allergy Asthma Immunol; 1996 May; 76(5):462-8. PubMed ID: 8630721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
    Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral albuterol in the treatment of childhood asthma.
    Rachelefsky GS; Katz RM; Siegel SC
    Pediatrics; 1982 Apr; 69(4):397-403. PubMed ID: 7070885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
    J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
    Weinstein SF; Pearlman DS; Bronsky EA; Byrne A; Arledge T; Liddle R; Stahl E
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):51-8. PubMed ID: 9690573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.